@article{4de93d89b4ee422c97784e4c3fddf09e,
title = "RNAi screening identifies a mechanosensitive ROCK-JAK2- STAT3 network central to myofibroblast activation",
abstract = "Myofibroblasts play key roles in wound healing and pathological fibrosis. Here, we used an RNAi screen to characterize myofibroblast regulatory genes, using a high-content imaging approach to quantify a-smooth muscle actin stress fibers in cultured human fibroblasts. Screen hits were validated on physiological compliance hydrogels, and selected hits tested in primary fibroblasts from patients with idiopathic pulmonary fibrosis. Our RNAi screen led to the identification of STAT3 as an essential mediator of myofibroblast activation and function. Strikingly, we found that STAT3 phosphorylation, while responsive to exogenous ligands on both soft and stiff matrices, is innately active on a stiff matrix in a ligand/receptor-independent, but ROCK- and JAK2-dependent fashion. These results demonstrate how a cytokine-inducible signal can become persistently activated by pathological matrix stiffening. Consistent with a pivotal role for this pathway in driving persistent fibrosis, a STAT3 inhibitor attenuated murine pulmonary fibrosis when administered in a therapeutic fashion after bleomycin injury. Our results identify novel genes essential for the myofibroblast phenotype, and point to STAT3 as an important target in pulmonary fibrosis and other fibrotic diseases.",
keywords = "Fibroblast, Fibrosis, SiRNA, Stiffness, TGF-β",
author = "Oh, {Raymond S.} and Haak, {Andrew J.} and Smith, {Karry M.J.} and Giovanni Ligresti and Choi, {Kyoung Moo} and Tiao Xie and Shaohua Wang and Walters, {Paula R.} and Thompson, {Michael A.} and Freeman, {Michelle R.} and Manlove, {Logan J.} and Chu, {Vivian M.} and Carol Feghali-Bostwick and Roden, {Anja C.} and J{\"u}rgen Schymeinsky and Pabelick, {Christina M.} and Prakash, {Y. S.} and Robert Vassallo and Tschumperlin, {Daniel J.}",
note = "Funding Information: Funding for this project was provided through a Boehringer Ingelheim/Harvard RNAi Screening Collaboration (to R.S.O. and D.J.T.) and by support from Thomas and Julie Hurvis and the Caerus Foundation; National Institutes of Health HL092961 and HL113796 (to D.J.T.), and P30 AR061271 and K24 AR060297 (to C.F.-B.). Deposited in PMC for release after 12 months. Funding Information: Funding for this project was provided through a Boehringer Ingelheim/Harvard RNAi Screening Collaboration (to R.S.O. and D.J.T.) and by support from Thomas and Julie Hurvis and the Caerus Foundation; National Institutes of Health HL092961 and HL113796 (to D.J.T.), and P30 AR061271 and K24 AR060297 (to C.F.-B.). Deposited in PMC for release after 12 months.The authors wish to acknowledge Andreas Schnapp at Boehringer-Ingelheim and Jennifer Smith, Stewart Rudnicki, Sean Johnston, DavidWrobel and Jen Nale at the Harvard Medical School Institute of Chemistry and Cell Biology Screening Facility, and Stephanie Mohr and Ian Flockhart at the Drosophila RNAi Screening Center for helpful discussions regarding design, implementation and interpretation of siRNA screen. Publisher Copyright: {\textcopyright} 2018. Published by The Company of Biologists Ltd.",
year = "2018",
month = may,
day = "15",
doi = "10.1242/jcs.209932",
language = "English (US)",
volume = "131",
journal = "Journal of cell science",
issn = "0021-9533",
publisher = "Company of Biologists Ltd",
number = "10",
}